GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Ending Cash Position

Biomics Biopharma (ASX:BBM) Ending Cash Position : A$0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Ending Cash Position?

Biomics Biopharma's Ending Cash Position for the quarter that ended in . 20 was A$0.00 Mil.


Biomics Biopharma Ending Cash Position Historical Data

The historical data trend for Biomics Biopharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Ending Cash Position Chart

Biomics Biopharma Annual Data
Trend
Ending Cash Position

Biomics Biopharma Semi-Annual Data
Ending Cash Position

Biomics Biopharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biomics Biopharma's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

Biomics Biopharma's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00


Biomics Biopharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines